This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
10 Apr 2025

Innovative investments

One of our most innovative initiatives is the implementation of ExtempoPrint – a cutting-edge technology that enhances precision in extemporaneous manufacturing through automated dispensing using 3D technology.

As the pharmaceutical industry trends towards more personalized medication supply, our role becomes increasingly pivotal. We specialize in manufacturing drugs with specific strengths and formulations tailored to patients with unique needs.

One of our most innovative initiatives is the implementation of ExtempoPrint – a cutting-edge technology that enhances precision in extemporaneous manufacturing through automated dispensing using 3D technology. This advancement not only improves dosage accuracy but also reduces production waste, thereby enhancing both the quality and sustainability of our manufacturing processes.

Mentioned Companies
APL
View company profile